Skip to main content
FMS logo

FMS · Fresenius Medical Care AG

Track FMS — free
$23.88 +0.32 (+1.34%)
Market Cap
$12.69B
Shares
532.22M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$23.56 Open$23.75 Day$23.55–23.89 52W close$20.19–27.41 Avg vol 30d701K Short int2.7M · 0.5% float · 4.3d Short vol24% Last earningsFeb 24, 2026 DataJan 2020–Aug 2026

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bullish Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 15.8 · calm Equity put/call 0.64
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +2%
above
Price vs 50-day avg −1%
below
RSI (14) 43
neutral
MACD trend Negative
52-week position 47%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −5%
trailing
6-month return +4%
trailing
YTD return −1%
this year
Relative strength −7%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $24 › 200d $23 — 50d above 200d
Institutional flow Accumulating
+6% holders QoQ · +48 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.50% of float · ▼ -0.2% MoM · 4.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
233 holders — near 3-yr high, broad support
Squeeze score 56
elevated · 0–100
Fundamentals
Strong
Revenue growth +6%
Y/Y
Gross margin 110%
expanding
EPS growth +20%
Y/Y
Free cash flow $1.1B
Balance sheet $7.1B
net debt
Quant / Vol
risk profile
Moderate
Volatility 30%
annualized · 1-yr
Max drawdown −26%
past year
ATR 2.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Mar 31, 2024
Same market treatment growth · this year 0.5% – 2%
Prior guidance period ended · from the Earnings Call filed Jun 30, 2025
U.S. same market treatment growth · 2025 at least 0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 5 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+2% Bullish
Price vs 50-day avg
−1% Neutral
RSI (14)
43 Neutral
MACD trend
Negative Bearish
52-week position
47% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $24 › 200d $23 — 50d above 200d
Institutional flow Accumulating
+6% holders QoQ · +48 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.50% of float · ▼ -0.2% MoM · 4.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
233 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $20 Now $24 · 47% Range high $27
vs 200-day avg +2% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
FMS
Fresenius Medical Care AG
this stock
$12.69B -1.1% +5.9% 0.5%
HCA
HCA Healthcare, Inc.
$89.84B -11.8% +7.1% 14.0 2.7%
FSNUY
Fresenius SE & Co. KGaA
$30.84B -5.3% 0.0%
THC
Tenet Healthcare Corp
$21.76B +36.0% +0.9% 10.4 4.0%
EHC
Encompass Health Corp
$12.07B +15.0% +10.5% 19.9 3.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
233
% held
8.0%
Net QoQ
+401.1K sh
Top holder
PZENA INVESTMENT MANAGEME…
Held Float
View
Held by Funds
Fund positions
23
View
Short & Settlement
Short Interest Falling
Shares short
2.7M
Days to cover
4.3d
Change
-4.4K sh
View
Short Volume
Short vol %
24%
As of
Aug 19, 2026
Short Total
View
Fails to Deliver
FTD shares
139.5K
Value
$3.4M
As of
Jul 27, 2026
View
Off-Exchange
Off-exchange %
28.8%
Week of
Jul 13, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Alan Armstrong
Amount
$1.0K–$15.0K
Traded
Mar 30, 2026
View
Financials
Financials
Revenue (FY)
$5.3B
Net income (FY)
$1.2B
EPS diluted
$4.06
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 4, 2026
This year
14
View
Proposed Sales
Value
$119.2K
Shares
5.7K
Filed
Dec 20, 2023
View
Earnings & Events
Earnings Calls
Last call
Feb 24, 2026
View
Investor Relations
Upcoming events
9
View

Performance

5D 20D 120D MTD YTD
FMS -1.3% -4.5% +4.0% -8.2% -1.1%
SPY -0.4% +2.6% +10.7% +2.7% +12.5%
vs SPY -0.9% -7.1% -6.7% -10.9% -13.6%

Capital returns

Latest dividend
$0.872 / share · ex May 22, 2026
Raised 7%
Paid (TTM)
$0.872 / share · 1 payout
Dividend yield (TTM, derived)
· history filling in

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1333141 CUSIP 358029106 13F (30d) 220 filings 208 filers Visit website Investor relations